Abstract

The reduction of the use chemical pesticides in agriculture is gaining importance as an objective of decision-makers in both politics and economics. Consequently, the development of technically efficient and economically affordable alternatives as, e.g., biological control agents or practices is highly solicited. Crown gall disease of dicotyledonous plants is caused by ubiquitous soil borne pathogenic bacteria of the Agrobacterium tumefaciens species complex, that comprises the species Agrobacterium fabrum and represents a globally relevant plant protection problem. Within the framework of a screening program for bacterial Agrobacterium antagonists a total of 14 strains were isolated from Tunisian soil samples and assayed for antagonistic activity against pathogenic agrobacteria. One particularly promising isolate, termed strain MBY2, was studied more in depth. Using a Multilocus Sequence Analysis (MLSA) approach, the isolate was assigned to the taxonomic species Bacillus velezensis. Strain MBY2 was shown to display antagonistic effects against the pathogenic A. fabrum strain C58 in vitro and to significantly decrease pathogen populations under sterile and non-sterile soil conditions as well as in the rhizosphere of maize and, to a lower extent, tomato plants. Moreover, the ability of B. velezensis MBY2 to reduce C58-induced gall development has been demonstrated in vivo on stems of tomato and almond plants. The present study describes B. velezensis MBY2 as a newly discovered strain holding potential as a biological agent for crown gall disease management.

Highlights

  • IntroductionMBY2 strain, a potential antagonist of crown gall disease

  • The present study aimed to investigate the crown gall biocontrol potential of the halotolerant Bacillus velezensis strain (MBY2) that had been isolated from saline soil in Tunisia

  • The present study aimed to identify new bacterial antagonist for the biological control of crown gall disease from the microbial communities of saline biotopes in Tunisia

Read more

Summary

Introduction

MBY2 strain, a potential antagonist of crown gall disease. 57587958 by the German Academic Exchange Service (DAAD) from funds of the German Federal Foreign Office (AA); grant 57247235 comprises a research scholarship to HBG. The authors declare that the funding body was not involved in study design, data collection, analysis, interpretation and writing of the study

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call